Arrowhead Pharmaceuticals' triglycerides-buster hit the "best-case scenario" in two studies Wednesda...
The 'Best-Case Scenario' That Shot Arrowhead Stock Sky-High
Arrowhead Pharmaceuticals' triglycerides-buster hit the "best-case scenario" in two studies Wednesday, leading the stock to skyrocket.
Author: Investor's Business Daily
Read Original Article